Correlation Between GeneReach Biotechnology and Dimension Computer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Dimension Computer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Dimension Computer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and Dimension Computer Technology, you can compare the effects of market volatilities on GeneReach Biotechnology and Dimension Computer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Dimension Computer. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Dimension Computer.

Diversification Opportunities for GeneReach Biotechnology and Dimension Computer

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between GeneReach and Dimension is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Dimension Computer Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dimension Computer and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Dimension Computer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dimension Computer has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Dimension Computer go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Dimension Computer

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Dimension Computer. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 2.17 times less risky than Dimension Computer. The stock trades about -0.09 of its potential returns per unit of risk. The Dimension Computer Technology is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2,490  in Dimension Computer Technology on December 5, 2024 and sell it today you would earn a total of  945.00  from holding Dimension Computer Technology or generate 37.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GeneReach Biotechnology  vs.  Dimension Computer Technology

 Performance 
       Timeline  
GeneReach Biotechnology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Dimension Computer 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dimension Computer Technology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dimension Computer showed solid returns over the last few months and may actually be approaching a breakup point.

GeneReach Biotechnology and Dimension Computer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneReach Biotechnology and Dimension Computer

The main advantage of trading using opposite GeneReach Biotechnology and Dimension Computer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Dimension Computer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dimension Computer will offset losses from the drop in Dimension Computer's long position.
The idea behind GeneReach Biotechnology and Dimension Computer Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals